Client Situation
An Australian company specialized in the development and commercialization of regenerative medicinal products wanted to commercialize its products in Brazil and needed support from a regulatory expert in Brazilian regulations to establish the RA strategy for the product’s registration in Brazil. The product is a collagen based medical device that facilitates tissue repair and healing in a variety of orthopedic. The devoce is considered very high risk in Brazil and classified as Class IV in Brazil.
